Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- Check5 days agoChange Detected- Added MedlinePlus Genetics topic coverage focusing on melanoma, expanding core content and mentioning a specific condition. No deletions were observed.SummaryDifference0.2%

- Check12 days agoChange Detected**Change summary:** Removed the MedlinePlus Genetics topic on Melanoma, narrowing the page's topic coverage related to melanoma within genetics content.SummaryDifference0.2%

- Check20 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check27 days agoChange DetectedUpdated the page to a new revision (v3.1.0) and added MedlinePlus Genetics content on Melanoma, replacing the previous revision v3.0.2.SummaryDifference0.3%

- Check34 days agoChange DetectedRemoved MedlinePlus Genetics topic on Melanoma, reducing available genetic information about this cancer on the page.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link/button was removed.SummaryDifference0.2%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.